Concepedia

Lavanya Diwakar

LD

27

Publications

3.1K

Citations

22

H-Index

2006

Active since

Affiliations

University of Birmingham(Current)

University of Oxford

Nottingham University Hospitals NHS Trust

University Hospitals of North Midlands NHS Trust

Cancer Research UK Clinical Trials Unit

Lavanya Diwakar is an author at University of Birmingham specializing in medicine, covid-19, and clinical epidemiology.

ORCID

Top concepts

Publications per year

2006–2024

27

Publications

27

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 555 citations · Full text

, , +7

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

, , +3

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 289 citations · Full text

Effect of HIV-1 Infection on T-Cell–based and Skin Test Detection of Tuberculosis Infection

Molebogeng X. Rangaka, Katalin A. Wilkinson, Ronnett Seldon et al. · American Journal of Respiratory and Critical Care Medicine · 2006 · 213 citations

Rows per page

1–5 of 27